Heparin in Acute Embolic Stroke Trial "HAEST"

Completed

Phase 3 Results

Summary of Purpose

To test whether treatment with low molecular weight heparin (LMWH) is superior to aspirin for the prevention of recurrent stroke during the first 14 days.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 21 September 2000.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

Multicenter, randomized, double-blind, and dummy-controlled trial of 449 patients.

Contacts

Not available